MCID: AST006
MIFTS: 44

Astigmatism malady

Category: Eye diseases

Aliases & Classifications for Astigmatism

About this section

Summaries for Astigmatism

About this section
Disease Ontology:11 A refractive error characterized by the optics of the eye to focus a point object into a sharp focused image on the retina, has symptom blurred vision.

MalaCards based summary: Astigmatism is related to nystagmus 5, congenital, x-linked and irregular astigmatism, and has symptoms including blurred vision, aniseikonia and aniseikonia. An important gene associated with Astigmatism is CACNA1F (Calcium Voltage-Gated Channel Subunit Alpha1 F). Affiliated tissues include eye, retina and endothelial.

Wikipedia:70 Astigmatism is a type of refractive error in which the eye does not focus light evenly on the retina.... more...

Related Diseases for Astigmatism

About this section

Diseases related to Astigmatism via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 89)
idRelated DiseaseScoreTop Affiliating Genes
1nystagmus 5, congenital, x-linked29.8CER1, GREM1
2irregular astigmatism12.1
3regular astigmatism12.0
4refractive error11.3
5keratoconus11.1
6amblyopia11.0
7ectopia lentis et pupillae10.8
8microcephaly with or without chorioretinopathy, lymphedema, or mental retardation10.8
9lymphedema-distichiasis syndrome10.8
10nystagmus 6, congenital, x-linked10.8
11aland island eye disease10.8
12megalocornea 1, x-linked10.8
13nystagmus 1, congenital, x-linked10.8
14lacrimal duct defect10.7
15nystagmus 7, congenital, autosomal dominant10.7
16keratoconus 510.7
17macrocephaly/megalencephaly syndrome, autosomal recessive10.7
18nystagmus 2, congenital, autosomal dominant10.7
19nystagmus 3, congenital, autosomal dominant10.7
20nystagmus 4, congenital, autosomal dominant10.7
21keratoconus 810.7
22keratoconus 110.7
23meesmann corneal dystrophy10.7
24retinitis pigmentosa10.7
25cataract10.5
26myopia10.5
27kyphoscoliotic heart disease10.4KRT12, KRT3
28stromal dystrophy10.4KRT12, KRT3
29oral mucosa leukoplakia10.4FRMD7, GPR143
30systolic heart failure10.3FRMD7, GPR143
31liver disease10.3KRT12, KRT3
32epidermolysis bullosa simplex, weber-cockayne type10.2KRT12, KRT3
33mucopolysaccharidosis10.2FRMD7, GPR143
34acute serous otitis media10.2KRT12, KRT3
35malignant tumor of undescended testis10.1ADAMTSL4, GREM1
36corneal dystrophy, epithelial basement membrane10.1KRT12, KRT3
37anisometropia10.1
38presbyopia10.0
39endotheliitis10.0
40cerebral artery occlusion10.0IFITM2, KRT12, KRT3
41epiblepharon9.9
42corneal ectasia9.8
43pellucid marginal degeneration9.8
44hemangioma9.8
45corneal degeneration9.8
46retinitis9.8
47eye disease9.8
48keratopathy9.7
49bullous keratopathy9.7
50capillary hemangioma9.7

Graphical network of the top 20 diseases related to Astigmatism:



Diseases related to astigmatism

Symptoms for Astigmatism

About this section

Symptoms:

 11
  • blurred vision

UMLS symptoms related to Astigmatism:


aniseikonia

Drugs & Therapeutics for Astigmatism

About this section

Drugs for Astigmatism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 102)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Hyaluronic acidapproved, vet_approvedPhase 44399004-61-953477741, 24759
Synonyms:
Hyaluronan
Hyaluronate
Hyaluronic acid
Hylartil
Hyruan Plus
Luronit
 
Macronan
Mucoitin
Nutra-HAF
Q 5AQ
Sepracoat
Sepragel Sinus
Sofast
Synvisc
2
DipivefrinapprovedPhase 4, Phase 39452365-63-63105
Synonyms:
( -)-2,2-Dimethylpropansaeure-4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylenester
( -)-4-(1-Hydroxy-2-methylaminoethyl)-o-phenylendipivalat
(+-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol 3,4-dipivalate
(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
(+-)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
(RS)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol
1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol
2,2-Dimethylpropanoic acid 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate)
52365-63-6
AB00514686
AC1L1F6K
AKOS003662293
AKPro
BPBio1_000688
BRD-A47494775-003-03-0
BSPBio_000624
C06963
C19H29NO5
CHEBI:4646
CID3105
D02349
DB00449
Dipivalyl Epinephrine
 
Dipivefrin
Dipivefrin (USAN)
Dipivefrin HCL
Dipivefrin [USAN]
Dipivefrina
Dipivefrina [INN-Spanish]
Dipivefrine
Dipivefrine (INN)
Dipivefrinum
Dipivefrinum [INN-Latin]
Dipivéfrine
K 30081
L000915
LS-121419
NCGC00179499-01
Ophtho-Dipivefrin
Prestwick0_000632
Prestwick1_000632
Prestwick2_000632
Prestwick3_000632
Pro-Epinephrine
Propine
Propine C Cap B.I.D.
SPBio_002843
UNII-8Q1PVL543G
[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate
dipivalyl epinephrine
dipivefrin
nchembio747-comp3
3
MentholapprovedPhase 4, Phase 323532216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
4
FluorouracilapprovedPhase 4179151-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
5
Bevacizumabapproved, investigationalPhase 41968216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
6AnestheticsPhase 4, Phase 2, Phase 39001
7ProxymetacainePhase 440
8Pharmaceutical SolutionsPhase 4, Phase 2, Phase 3, Phase 17793
9Neurotransmitter AgentsPhase 417734
10Adrenergic AgonistsPhase 42877
11Adrenergic AgentsPhase 45140
12Antimetabolites, AntineoplasticPhase 47171
13Immunosuppressive AgentsPhase 412770
14Angiogenesis Modulating AgentsPhase 44072
15Angiogenesis InhibitorsPhase 44143
16AntimetabolitesPhase 411774
17
Lidocaineapproved, vet_approvedPhase 2, Phase 31226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
18
Folic Acidapproved, nutraceutical, vet_approvedPhase 2, Phase 3, Phase 1427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
19
Riboflavinapproved, nutraceutical, vet_approvedPhase 2, Phase 3, Phase 116583-88-5493570
Synonyms:
(-)-Riboflavin
1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol
1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol
6,7-Dimethyl-9-D-ribitylisoalloxazine
6,7-Dimethyl-9-ribitylisoalloxazine
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-Benzo[g]pteridine-2,4(3H,10H)-dione
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine
7,8-Dimethyl-10-ribitylisoalloxazine
Beflavin
Beflavine
Benzo[g]pteridine riboflavin deriv.
E 101
E101
Flavaxin
Flavin BB
Flaxain
Food Yellow 15
 
Hyre
Lactobene
Lactoflavin
Lactoflavine
Ribipca
Ribocrisina
Riboderm
Riboflavina
Riboflavine
Riboflavinum
Ribosyn
Ribotone
Ribovel
Russupteridine yellow III
San Yellow B
Vitaflavine
Vitamin B2
Vitamin G
Vitasan B2
20
Flavin MononucleotideexperimentalPhase 2, Phase 36146-17-8643976
Synonyms:
FMN
Flanin
Flavine mononucleotide
Flavol
Riboflavin
Riboflavin 5'-monophosphate
Riboflavin 5'-phosphate
Riboflavin Mononucleotide
Riboflavin monophosphate
 
Riboflavin phosphate
Riboflavin-5'-phosphate na
Riboflavin-5-phosphate
Riboflavine 5'-monophosphate
Riboflavine 5'-phosphate
Riboflavine dihydrogen phosphate
Riboflavine monophosphate
Riboflavine phosphate
Riboflavine-5'-phosphate
Vitamin B2 phosphate
21Photosensitizing AgentsPhase 2, Phase 3, Phase 1476
22VitaminsPhase 2, Phase 3, Phase 15095
23Ophthalmic SolutionsPhase 3, Phase 1, Phase 21092
24MitomycinsPhase 3, Phase 1233
25Peripheral Nervous System AgentsPhase 2, Phase 322776
26Vitamin B ComplexPhase 2, Phase 3, Phase 14229
27Sodium Channel BlockersPhase 2, Phase 31515
28Trace ElementsPhase 2, Phase 3, Phase 15802
29MicronutrientsPhase 2, Phase 3, Phase 15802
30Central Nervous System DepressantsPhase 2, Phase 312806
31Anti-Arrhythmia AgentsPhase 2, Phase 32969
32DextransPhase 2, Phase 3, Phase 199
33Dermatologic AgentsPhase 2, Phase 3, Phase 15674
34Anesthetics, LocalPhase 2, Phase 33272
35Diuretics, Potassium SparingPhase 2, Phase 31827
36Protective AgentsPhase 37190
37Vasodilator AgentsPhase 33438
38Polymethyl MethacrylatePhase 342
39Blood SubstitutesPhase 3, Phase 1, Phase 2246
40Plasma SubstitutesPhase 3, Phase 1, Phase 2233
41AnticoagulantsPhase 3, Phase 1, Phase 22516
42FolateNutraceuticalPhase 2, Phase 3, Phase 14279
43Vitamin B2NutraceuticalPhase 2, Phase 3, Phase 1165
44Vitamin B9NutraceuticalPhase 2, Phase 3, Phase 14279
45Anti-Bacterial AgentsPhase 2, Phase 110884
46MydriaticsPhase 2, Phase 1, Early Phase 1763
47Anti-Infective AgentsPhase 221402
48Nucleic Acid Synthesis InhibitorsPhase 14855
49Alkylating AgentsPhase 14694
50Antibiotics, AntitubercularPhase 16972

Interventional clinical trials:

(show top 50)    (show all 252)
idNameStatusNCT IDPhase
1Effect of Posterior Corneal Toricity on Refractive Outcome of PseudophakiaUnknown statusNCT01554761Phase 4
2Clinical Evaluation of Toric Intraocular Lens Made by AurolabUnknown statusNCT01396616Phase 4
3A Intra-patient Comparison of Closed Loop and Plate Haptic Toric Intraocular LensesUnknown statusNCT02264457Phase 4
4Multi Laser Platform Comparison Study for LASIKUnknown statusNCT00770094Phase 4
5Use of Toric Intraocular Lens to Neutralize Keratometric AstigmatismCompletedNCT00925886Phase 4
6Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal AstigmatismCompletedNCT01763151Phase 4
7Intrastromal Corneal Ring for High Astigmatism on PostkeratoplastyCompletedNCT01018797Phase 4
8Clinical Performance of Biofinity Toric Versus Air Optix for AstigmatismCompletedNCT01965288Phase 4
9Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy.CompletedNCT01885780Phase 4
10Safety and Effectiveness of the Akreos Toric Intraocular Lens.CompletedNCT00825513Phase 4
11Clinical Performance of Habitual Hydrogel vs. Silicone Hydrogel Toric Contact LensesCompletedNCT02142361Phase 4
12Contralateral Comparison of Three Excimer Laser Systems in Performing LASIKCompletedNCT00821236Phase 4
13Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled TrialCompletedNCT01279031Phase 4
14AcrySof Toric Clinical ResultsCompletedNCT01214863Phase 4
15Low Cylinder ToricCompletedNCT00732030Phase 4
16An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic PatientsCompletedNCT01173198Phase 4
17Visual Outcomes After Implantation of a New Multifocal Intraocular LensCompletedNCT01505816Phase 4
18Daily Wear Corneal Infiltrative Event StudyCompletedNCT00937105Phase 4
19Co-Axial Micro-Incision Versus Co-Axial Small Incision Cataract Surgery Using the Stellaris Enhancement SystemCompletedNCT01261975Phase 4
20Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate IncisionsRecruitingNCT02763124Phase 4
21High Resolution Wavefront-guided vs. Wavefront Optimized LASIKRecruitingNCT02565537Phase 4
22Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Lens (IOL)RecruitingNCT02649842Phase 4
23Prospective Investigation of SUPRACOR Visual Outcomes of Presbyopic Hyperopic Patients With and Without AstigmatismActive, not recruitingNCT01628146Phase 4
24LASIK Using the Alcon Allegretto Wavefront-Guided Excimer Laser vs AMO Visx Wavefront-Guided Excimer LaserActive, not recruitingNCT01454843Phase 4
25Wavefront-guided PRK vs Wavefront-optimized PRKActive, not recruitingNCT02091934Phase 4
26Wavefront-guided Photorefractive Keratectomy (PRK) Versus Wavefront-guided Lasik for MyopiaActive, not recruitingNCT01140594Phase 4
27Strategies for Management of Recurrent PterygiumNot yet recruitingNCT02530801Phase 4
28Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® ToricWithdrawnNCT00761488Phase 4
29Evaluation of the BunnyLens TR Intraocular LensUnknown statusNCT01659801Phase 3
30Intrastromal Correction of Ametropia by a Femtosecond LaserUnknown statusNCT00928122Phase 3
31Comparison of Penetrating Keratoplasty and Deep Lamellar Keratoplasty With the Big Bubble Technique for KeratoconusUnknown statusNCT00371202Phase 3
32Corneal Cross Linking and Topography Guided Excimer Laser TreatmentUnknown statusNCT01682993Phase 3
33Treatment of Keratoconus Using Collagen Cross-LinkingUnknown statusNCT00841386Phase 2, Phase 3
34Economic Evaluation of Femtosecond Laser Assisted Cataract SurgeryUnknown statusNCT01982006Phase 3
35Comparison of Cross-cylinder and Conventional Photorefractive Keratectomy(PRK) in Correcting Medium-high AstigmatismCompletedNCT00663923Phase 3
36The Berkeley Orthokeratology StudyCompletedNCT00000123Phase 3
37Multicenter Evaluation of Safety and Effectiveness of Presbyopic LASIK for HyperopesCompletedNCT00910403Phase 3
38A Prospective Study of Femtosecond Laser Intracorneal LensectomiCompletedNCT01673503Phase 3
39Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical HeterophoriaCompletedNCT00785135Phase 3
40Evaluating the Safety and Efficacy of the KXL System for Corneal Collagen Cross-Linking in Eyes Having KeratoconusRecruitingNCT02638376Phase 3
41Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical TrialRecruitingNCT01604135Phase 3
42Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed AstigmatismActive, not recruitingNCT01675492Phase 3
43SUPRACOR for Myopia and Myopic AstigmatismActive, not recruitingNCT01404884Phase 3
44Clinical Evaluation of CATS Tonometer PrismNot yet recruitingNCT02989909Phase 3
45Complete Easy Rub Comparative Efficacy StudyWithdrawnNCT01019564Phase 3
46Myoring Versus Keraring Implantation for KeratoconusUnknown statusNCT01869517Phase 2
47Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecond Laser SystemCompletedNCT01348854Phase 2
48Wavefront Analyzes and Visual Performance of Three Multifocal Intra-ocular LensesCompletedNCT00876707Phase 1, Phase 2
49Is Non-cycloplegic Photorefraction Applicable for Screening Refractive Risk Factors of Amblyopia?CompletedNCT01308307Phase 2
50Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose SolutionsCompletedNCT01024855Phase 1, Phase 2

Search NIH Clinical Center for Astigmatism


Cochrane evidence based reviews: astigmatism

Genetic Tests for Astigmatism

About this section

Genetic tests related to Astigmatism:

id Genetic test Affiliating Genes
1 Astigmatism26

Anatomical Context for Astigmatism

About this section

MalaCards organs/tissues related to Astigmatism:

35
Eye, Retina, Endothelial, Testes

Animal Models for Astigmatism or affiliated genes

About this section

Publications for Astigmatism

About this section

Articles related to Astigmatism:

(show top 50)    (show all 739)
idTitleAuthorsYear
1
Comparison of Toric Foldable Iris-Fixated Phakic Intraocular Lens Implantation and Limbal Relaxing Incisions for Moderate-to-High Myopic Astigmatism. (27593877)
2016
2
Ocular residual astigmatism (ORA) in pre-cataract eyes prior to and after refractive lens exchange. (27624172)
2016
3
Comparison of Astigmatism Induced by Combined Inferior Oblique Anterior Transposition Procedure and Lateral Rectus Recession Alone. (27980365)
2016
4
Long-term follow-up of astigmatic keratotomy for corneal astigmatism after penetrating keratoplasty. (27150121)
2016
5
Analysis of cataract surgery induced astigmatism: Two polar methods comparison. (28040496)
2016
6
Development of a program for toric intraocular lens calculation considering posterior corneal astigmatism, incision-induced posterior corneal astigmatism, and effective lens position. (27541160)
2016
7
Residual astigmatism after toric intraocular lens implantation: Analysis of data from an online toric intraocular lens back-calculator. (27956286)
2016
8
Adjustment of anterior corneal astigmatism values to incorporate the likely effect of posterior corneal curvature for toric intraocular lens calculation. (25735042)
2015
9
Prevalence of corneal astigmatism before cataract surgery in Caucasian patients. (24366768)
2013
10
Predicting ocular residual astigmatism using corneal and refractive parameters: a myopic eye study. (23621376)
2013
11
Three-year follow-up of posterior chamber toric phakic intraocular lens implantation for moderate to high myopic astigmatism. (23409187)
2013
12
Wearing time as a measure of success of scleral lenses for patients with irregular astigmatism. (24145901)
2013
13
Effects of induced astigmatism on foot placement strategies when stepping onto a raised surface. (23717414)
2013
14
Heritability of refractive astigmatism: a population-based twin study among 63- to 75-year-old female twins. (23950154)
2013
15
Astigmatism in patients with idiopathic congenital nystagmus. (23456100)
2013
16
Effect of preoperative corneal astigmatism orientation on results with a toric intraocular lens. (24140375)
2013
17
Analysis of internal astigmatism and higher order aberrations in eyes implanted with a new diffractive multifocal toric intraocular lens. (22588290)
2013
18
Effects of pterygium surgery on front and back corneal astigmatism. (23036543)
2012
19
Perceptual adaptation to the correction of natural astigmatism. (23050021)
2012
20
Corneal astigmatism after micro-incision cataract operation. (22486146)
2012
21
Iris-fixated toric phakic intraocular lens for myopic astigmatism. (22613689)
2012
22
Contribution of posterior corneal astigmatism to total corneal astigmatism. (23069271)
2012
23
Time course of refractive and corneal astigmatism after laser in situ keratomileusis for moderate to high astigmatism. (22814047)
2012
24
Can opposite clear corneal incisions have a role with post-laser in situ keratomileusis astigmatism? (22623863)
2012
25
Wavefront-guided versus cross-cylinder photorefractive keratectomy in moderate-to-high astigmatism: a cohort of two consecutive clinical trials. (22331978)
2012
26
Collagen crosslinking and toric iris-claw phakic intraocular lens for myopic astigmatism in progressive mild to moderate keratoconus. (22261324)
2012
27
Implantation of intrastromal corneal ring segments for post-keratoplasty astigmatism. (23079334)
2012
28
Clinical results of topography-based customized ablations for myopia and myopic astigmatism. (23447897)
2012
29
Postoperative astigmatism in the second eye undergoing cataract surgery. (21402984)
2011
30
Correction of astigmatism during cataract surgery: toric intraocular lens compared to peripheral corneal relaxing incisions. (20873707)
2011
31
Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma. (20970771)
2011
32
Keratoconus-integrated characterization considering anterior corneal aberrations, internal astigmatism, and corneal biomechanics. (21333878)
2011
33
Toric soft contact lens fit in a postoperative LASIK keratoectasia patient with high and irregular astigmatism. (22019833)
2011
34
Keratometry measurements, corneal astigmatism and irregularity in a normal population: the Tehran Eye Study. (21205266)
2010
35
Collagen copolymer toric posterior chamber phakic intraocular lenses to correct high myopic astigmatism. (20656159)
2010
36
Success rates in the correction of astigmatism with toric and spherical soft contact lens fittings. (20856589)
2010
37
Microincision cataract surgery with toric intraocular lens implantation for correcting moderate and high astigmatism: pilot study. (20117704)
2010
38
Copolymer-based progressive addition lens with graded index designed for astigmatism and distortion correction. (20356016)
2009
39
Astigmatism terminology. (18721693)
2008
40
Phakic toric Implantable Collamer Lens implantation for the correction of high myopic astigmatism in eyes with keratoconus. (18856240)
2008
41
Limbal relaxing incisions to correct corneal astigmatism during phacoemulsification. (17523513)
2007
42
Corneal astigmatism with upper eyelid gold weight implantation using the combined high pretarsal and levator fixation technique. (17881989)
2007
43
Bungee cord-induced corneal lacerations correcting for myopic astigmatism. (17586399)
2007
44
Strategic planning in topography-guided ablation of irregular astigmatism after laser refractive surgery. (16128335)
2005
45
Intraocular lens implantation and laser in situ keratomileusis (bioptics) to correct high myopia and hyperopia with astigmatism. (11316030)
2001
46
Management of irregular astigmatism. (10977770)
2000
47
Laser in situ keratomileusis for hyperopia and hyperopic astigmatism. (9571548)
1998
48
Disciform keratitis causing severe irregular astigmatism. (8743008)
1996
49
Escalation of keratospeak: regular and irregular astigmatism. (2248932)
1990
50
Can Staphyloma Posticum be induced by Astigmatism? (25258805)
1875

Variations for Astigmatism

About this section

Expression for genes affiliated with Astigmatism

About this section
Search GEO for disease gene expression data for Astigmatism.

Pathways for genes affiliated with Astigmatism

About this section

GO Terms for genes affiliated with Astigmatism

About this section

Biological processes related to Astigmatism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1determination of dorsal identityGO:00482639.8CER1, GREM1
2negative regulation of BMP signaling pathwayGO:00305149.4CER1, GREM1
3visual perceptionGO:00076019.3CACNA1F, GPR143, KRT12, VAX2

Molecular functions related to Astigmatism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1morphogen activityGO:00160159.3CER1, GREM1
2BMP bindingGO:00361229.0CER1, GREM1

Sources for Astigmatism

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet